SUSAN MARRIOTT to Terminal Repeat Sequences
This is a "connection" page, showing publications SUSAN MARRIOTT has written about Terminal Repeat Sequences.
Connection Strength
0.936
-
Activation of the human T-cell leukemia virus type 1 long terminal repeat by the ternary complex factor Elk-1. J Virol. 2007 Dec; 81(23):13075-81.
Score: 0.276
-
Identification of a functional serum response element in the HTLV-I LTR. Virology. 2004 Jul 01; 324(2):540-53.
Score: 0.221
-
T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1. J Virol. 2003 Oct; 77(20):11170-9.
Score: 0.209
-
Human T-cell lymphotropic virus type 3 (HTLV-3)- and HTLV-4-derived antisense transcripts encode proteins with similar Tax-inhibiting functions but distinct subcellular localization. J Virol. 2011 Dec; 85(23):12673-85.
Score: 0.091
-
HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated. Retrovirology. 2006 Mar 02; 3:15.
Score: 0.062
-
Identification of an initiator-like element within the HTLV-I promoter. Virology. 2001 Feb 01; 280(1):72-9.
Score: 0.044
-
Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4. Retrovirology. 2009 Feb 02; 6:9.
Score: 0.019
-
Activation of HTLV-I gene transcription by protein tyrosine phosphatase inhibitors. Virology. 2004 Nov 24; 329(2):395-411.
Score: 0.014